These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

297 related items for PubMed ID: 6272965

  • 1. Long-term T-cell-mediated immunity to Epstein-Barr virus.
    Rickinson AB, Moss DJ, Wallace LE, Rowe M, Misko IS, Epstein MA, Pope JH.
    Cancer Res; 1981 Nov; 41(11 Pt 1):4216-21. PubMed ID: 6272965
    [No Abstract] [Full Text] [Related]

  • 2. Epstein Barr virus selective T cells in infectious mononucleosis are not restricted to HLA-A and B antigens.
    Seeley J, Svedmyr E, Weiland O, Klein G, Moller E, Eriksson E, Andersson K, van der Waal L.
    J Immunol; 1981 Jul; 127(1):293-300. PubMed ID: 6263974
    [No Abstract] [Full Text] [Related]

  • 3. Cell-mediated immunity against Epstein-Barr virus infected B lymphocytes.
    Klein E, Masucci MG.
    Springer Semin Immunopathol; 1982 Jul; 5(1):63-73. PubMed ID: 6314570
    [No Abstract] [Full Text] [Related]

  • 4. Cytotoxic T cell recognition of Epstein-Barr virus-infected B cells. II. Blocking studies with monoclonal antibodies to HLA determinants.
    Wallace LE, Moss DJ, Rickinson AB, McMichael AJ, Epstein MA.
    Eur J Immunol; 1981 Sep; 11(9):694-9. PubMed ID: 6271557
    [Abstract] [Full Text] [Related]

  • 5. T-cell response to B-cells and Epstein-Barr virus antigens in infectious mononucleosis.
    Klein E, Ernberg I, Masucci MG, Szigeti R, Wu YT, Masucci G, Svedmyr E.
    Cancer Res; 1981 Nov; 41(11 Pt 1):4210-5. PubMed ID: 6272964
    [Abstract] [Full Text] [Related]

  • 6. T-cell control of herpesvirus infections: lessons from the Epstein-Barr virus.
    Rickinson AB.
    Prog Brain Res; 1983 Nov; 59():189-202. PubMed ID: 6320264
    [No Abstract] [Full Text] [Related]

  • 7. Summary: symposium on Epstein-Barr virus-induced lymphoproliferative diseases in immunodeficient patients.
    Klein G, Purtilo D.
    Cancer Res; 1981 Nov; 41(11 Pt 1):4302-4. PubMed ID: 6272974
    [No Abstract] [Full Text] [Related]

  • 8. The MLC response of patients with infectious mononucleosis to Epstein-Barr virus-transformed cells.
    Wasik M, Myc A, Matej H, Rudzka L.
    Arch Immunol Ther Exp (Warsz); 1983 Nov; 31(6):871-8. PubMed ID: 6331340
    [Abstract] [Full Text] [Related]

  • 9. Specificity of monoclonal antibodies to an EBV transformed B-cell line.
    Schröder J, Suomalainen HA, Parkkinen E, Lundqvist C, Wada G, Koskimies S.
    Med Biol; 1982 Oct; 60(5):255-9. PubMed ID: 6296556
    [Abstract] [Full Text] [Related]

  • 10. Education of mouse lymphocytes against human lymphoblastoid cell lines: specific recognition of determinants independent of serologically defined HLA allotypes and Epstein-Barr virus-coded antigens.
    Carnaud C, Errasti P, van der Gaag R.
    Eur J Immunol; 1979 Oct; 9(10):802-8. PubMed ID: 93053
    [No Abstract] [Full Text] [Related]

  • 11. The suppression of Epstein-Barr virus infection in vitro occurs after infection but before transformation of the cell.
    Thorley-Lawson DA.
    J Immunol; 1980 Feb; 124(2):745-51. PubMed ID: 6243331
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of the in vitro outgrowth of Epstein-Barr virus-transformed lymphocytes by thymus-dependent lymphocytes from infectious mononucleosis patients.
    Rickinson AB, Crawford D, Epstein MA.
    Clin Exp Immunol; 1977 Apr; 28(1):72-9. PubMed ID: 193663
    [Abstract] [Full Text] [Related]

  • 13. Stimulation of human lymphocytes with irradiated cells of the autologous Epstein-Barr virus-transformed cell line. I. Virus-specific and nonspecific components of the cytotoxic response.
    Wallace LE, Rickinson AB, Rowe M, Moss DJ, Allen DJ, Epstein MA.
    Cell Immunol; 1982 Feb; 67(1):129-40. PubMed ID: 6176332
    [No Abstract] [Full Text] [Related]

  • 14. [Epstein-Barr virus and its role in various rheumatic diseases].
    Anan'eva LP, Alekberova ZS, Barinskii IF, Nasonova VA.
    Ter Arkh; 1983 Feb; 55(7):140-6. PubMed ID: 6312625
    [No Abstract] [Full Text] [Related]

  • 15. Human virus-infected target cells lacking HLA antigens resist specific T-lymphocyte cytolysis.
    Tursz T, Fridman WH, Senik A, Tsapis A, Fellous M.
    Nature; 1977 Oct 27; 269(5631):806-8. PubMed ID: 200845
    [No Abstract] [Full Text] [Related]

  • 16. Epstein-barr-virus nuclear antigen.
    Vonka V, Hirsch I.
    Prog Med Virol; 1982 Oct 27; 28():145-79. PubMed ID: 6283600
    [No Abstract] [Full Text] [Related]

  • 17. [Role of the Epstein-Barr virus in human pathology].
    Rupniewska ZM.
    Acta Haematol Pol; 1979 Oct 27; 10(3):183-91. PubMed ID: 228518
    [No Abstract] [Full Text] [Related]

  • 18. Infectious mononucleosis and Epstein-Barr virus in Japan. II. Cellular aspects.
    Takiuchi Y, Tatsumi E, Nasu K, Shirakawa S, Uchino H.
    Nihon Ketsueki Gakkai Zasshi; 1981 Jul 27; 44(4):864-71. PubMed ID: 6277135
    [No Abstract] [Full Text] [Related]

  • 19. Epstein-Barr virus-specific cytoskeletal early antigen in EBV-transformed cell lines.
    Sairenji T, Nguyen QV, Woda B, Humphreys RE.
    AIDS Res; 1986 Dec 27; 2 Suppl 1():S57-60. PubMed ID: 3030348
    [Abstract] [Full Text] [Related]

  • 20. Generation of long-term human cytolytic cell lines with persistent natural killer activity.
    Krensky AM, Ault KA, Reiss CS, Strominger JL, Burakoff SJ.
    J Immunol; 1982 Oct 27; 129(4):1748-51. PubMed ID: 6286775
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.